GSK plc reported £32.7B of revenue over the trailing twelve months, +4.1% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: £32.7B (to FY2025). Net Income: £5.72B, trailing twelve months to FY2025. Free Cash Flow: £6.39B, trailing twelve months to FY2025. Op Margin: 24%, trailing twelve months to FY2025.

GSKGSK plc

HealthcareUSD

$48.57

$37.9752 weeks$60.14

GSK as reported

GSK plc reported £32.7B of revenue over the trailing twelve months, +4.1% on the year before. 10 reported series are charted on this page, each one as filed.

£32.7B

Revenue, trailing twelve months · to FY2025 · +4.1% against the twelve months before

Net Income: £5.72B
Net Income · +122% year on year · trailing twelve months to FY2025
Free Cash Flow: £6.39B
Free Cash Flow · +24% year on year · trailing twelve months to FY2025
Op Margin: 24%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for GSK, trailing twelve months
Series	Latest	Year on year	As of
Revenue	£32.7B	+4.1%	FY2025
Net Income	£5.72B	+122%	FY2025
EPS	£1.39	+123%	FY2025
Gross Margin	72%	n/a	FY2025
Op Margin	24%	n/a	FY2025
Net Margin	17%	n/a	FY2025
ROE	35%	n/a	FY2025
ROA	9.4%	n/a	FY2025
ROIC	20%	n/a	FY2025
Free Cash Flow	£6.39B	+24%	FY2025